These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 28851616
1. Regulation of gonadotropins by urocortin 2 in gonadotropic tumor LβT2 cells. Kageyama K, Murasawa S, Niioka K, Otsuka F, Yagi H, Daimon M. Neurosci Lett; 2017 Nov 01; 660():63-67. PubMed ID: 28851616 [Abstract] [Full Text] [Related]
2. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells. Yamagata S, Kageyama K, Akimoto K, Watanuki Y, Suda T, Daimon M. Peptides; 2013 Dec 01; 50():1-7. PubMed ID: 24083959 [Abstract] [Full Text] [Related]
3. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats. Pintér D, Balangó B, Simon B, Palotai M, Csabafi K, Dobó É, Ibos KE, Bagosi Z. Neuropeptides; 2021 Aug 01; 88():102147. PubMed ID: 33932861 [Abstract] [Full Text] [Related]
4. Differential regulation of gonadotropin-releasing hormone by corticotropin-releasing factor family peptides in hypothalamic N39 cells. Kageyama K, Hasegawa G, Akimoto K, Yamagata S, Tamasawa N, Suda T. Peptides; 2012 Jan 01; 33(1):149-55. PubMed ID: 22138165 [Abstract] [Full Text] [Related]
9. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner. Dermitzaki E, Tsatsanis C, Minas V, Chatzaki E, Charalampopoulos I, Venihaki M, Androulidaki A, Lambropoulou M, Spiess J, Michalodimitrakis E, Gravanis A, Margioris AN. Endocrinology; 2007 Apr 01; 148(4):1524-38. PubMed ID: 17194738 [Abstract] [Full Text] [Related]
10. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Hashimoto K, Nishiyama M, Tanaka Y, Noguchi T, Asaba K, Hossein PN, Nishioka T, Makino S. Peptides; 2004 Oct 01; 25(10):1711-21. PubMed ID: 15476938 [Abstract] [Full Text] [Related]
15. Differential effects of gonadotropin-releasing hormone (GnRH) pulse frequency on gonadotropin subunit and GnRH receptor messenger ribonucleic acid levels in vitro. Kaiser UB, Jakubowiak A, Steinberger A, Chin WW. Endocrinology; 1997 Mar 01; 138(3):1224-31. PubMed ID: 9048630 [Abstract] [Full Text] [Related]
16. Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes. Dermitzaki E, Liapakis G, Androulidaki A, Venihaki M, Melissas J, Tsatsanis C, Margioris AN. PLoS One; 2014 Mar 01; 9(5):e97060. PubMed ID: 24835211 [Abstract] [Full Text] [Related]
17. Involvement of Nurr-1/Nur77 in corticotropin-releasing factor/urocortin1-induced tyrosinase-related protein 1 gene transcription in human melanoma HMV-II cells. Watanuki Y, Takayasu S, Kageyama K, Iwasaki Y, Sakihara S, Terui K, Nigawara T, Suda T. Mol Cell Endocrinol; 2013 May 06; 370(1-2):42-51. PubMed ID: 23416839 [Abstract] [Full Text] [Related]
18. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. Proc Natl Acad Sci U S A; 2001 Jun 19; 98(13):7570-5. PubMed ID: 11416224 [Abstract] [Full Text] [Related]